Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct 1;46(7):e501-e507.
doi: 10.1097/MPH.0000000000002938. Epub 2024 Aug 26.

Refractory Thrombocytopenia is the Earliest Diagnostic Criterion for Sinusoidal Obstruction Syndrome in Children

Affiliations

Refractory Thrombocytopenia is the Earliest Diagnostic Criterion for Sinusoidal Obstruction Syndrome in Children

Filippo Consonni et al. J Pediatr Hematol Oncol. .

Abstract

Sinusoidal obstruction syndrome (SOS) is a life-threatening complication of hematopoietic stem cell transplantation (HSCT), whose diagnostic criteria changed over time to achieve a timelier diagnosis. Recently, pediatric-specific criteria presented by the European Society for Blood and Marrow Transplantation (pEBMT) incorporated transfusion-refractory thrombocytopenia (RT) as an early indicator of SOS in children. However, a comparison of all individual diagnostic parameters belonging to pEBMT and former SOS diagnostic criteria has never been performed. This retrospective study conducted at a pediatric tertiary care hospital analyzed all pediatric HSCT cases diagnosed with SOS among 170 children transplanted from 2009 to 2023. Eleven patients developed SOS during this period (incidence: 11/170, 6.5%). pEBMT, Seattle, and Baltimore criteria were retrospectively applied to the 11 cases and compared, showing that RT was the earliest fulfilled parameter (median onset: 6 d post-HSCT). pEBMT and Seattle criteria identified 11/11 SOS cases, with pEBMT leading to an earlier diagnosis. RT typically manifested before diagnosis, with significantly higher platelet transfusion requirements before diagnosis than after. RT is the earliest satisfied criterion in pediatric SOS and typically occurs in the initial stages of the disease before diagnosis. Further research is needed to identify additional early indicators of pediatric SOS.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
Retrospective assessment of SOS diagnostic criteria in included patients. A, Venn diagram showing the number of patients diagnosed through a retrospective application of each diagnostic criteria. B, Scatter plot showing the time required for each criterion to be satisfied in included patients. C, Violin plot showing the time required for each specific parameter of the 3 assessed criteria to be satisfied. Refractory thrombocytopenia (RT) was satisfied significantly earlier than any other parameter. BAL/Baltimore indicates Baltimore criteria; pEBMT, pediatric European Society for Blood and Marrow Transplantation criteria; SEA/Seattle, modified Seattle criteria. ***P<0.001.
FIGURE 2
FIGURE 2
Order of appearance of the 5 parameters belonging to pEBMT criteria in included patients. pEBMT indicates pediatric European Society for Blood and Marrow Transplantation criteria; RT, refractory thrombocytopenia.
FIGURE 3
FIGURE 3
Refractoriness to platelet transfusions before and after diagnosis of SOS in included patients. A, Percentage of days in which the patient required platelet (PLT) transfusions before and after diagnosis of SOS. B, Platelet transfusion requirement (PTR) before and after diagnosis of SOS. C, Heat map showing the days when platelets were transfused (colored squares), and the amount (mL/kg) of platelet transfused for each included patient. Gray squares indicate days where platelets were not transfused. The yellow cross indicates the day when the diagnosis of SOS was established in clinical practice. The heat map shows that the days where platelets were transfused are highly distributed in the prediagnosis period.

References

    1. Mohty M, Malard F, Abecasis M, et al. . Prophylactic, preemptive, and curative treatment for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a position statement from an international expert group. Bone Marrow Transplant. 2020;55:485–495. - PMC - PubMed
    1. Corbacioglu S, Carreras E, Ansari M, et al. . Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and marrow transplantation. Bone Marrow Transplant. 2018;53:138–145. - PMC - PubMed
    1. Bonifazi F, Barbato F, Ravaioli F, et al. . Diagnosis and treatment of VOD/SOS after allogeneic hematopoietic stem cell transplantation. Front Immunol. 2020;11(April):1–13. - PMC - PubMed
    1. Corbacioglu S, Greil J, Peters C, et al. . Defibrotide in the treatment of children with veno-occlusive disease (VOD): a retrospective multicentre study demonstrates therapeutic efficacy upon early intervention. Bone Marrow Transplant. 2004;33:189–195. - PubMed
    1. Kernan NA, Grupp S, Smith AR, et al. . Final results from a defibrotide treatment-IND study for patients with hepatic veno-occlusive disease/sinusoidal obstruction syndrome. Br J Haematol. 2018;181:816–827. - PMC - PubMed

Publication types